FOXA2 controls the anti-oxidant response in FH-deficient cells

Area of Science:

• Oncology
• Molecular Biology
• Epigenetics

Background:

• Hereditary leiomyomatosis and renal cell cancer (HLRCC) is a cancer syndrome resulting from germline mutations in the fumarate hydratase (FH) gene.
• FH mutations lead to fumarate accumulation, causing epigenetic alterations and activating antioxidant responses through NRF2.
• The role of chromatin remodeling in shaping these antioxidant responses in FH-deficient cells remains unclear.

Purpose of the Study:

• To investigate the impact of FH loss on the chromatin landscape in FH-deficient cells.
• To identify transcription factor networks involved in the remodeled chromatin of these cells.
• To understand the molecular mechanisms underlying cellular responses to fumarate accumulation in HLRCC.

Main Methods:

• Analysis of chromatin landscape alterations in FH-deficient cells.
• Identification of key transcription factors regulating antioxidant response genes.
• Investigation of interactions between identified transcription factors and known regulators like NRF2.

Main Results:

• FH loss significantly remodels the chromatin landscape in affected cells.
• FOXA2 is identified as a crucial transcription factor regulating antioxidant response genes.
• FOXA2 cooperates with NRF2 in regulating metabolic rewiring, despite lacking direct interaction.

Conclusions:

• FOXA2 plays a significant role in mediating antioxidant responses and metabolic adaptation in the context of FH deficiency.
• The findings provide novel insights into the molecular pathogenesis of HLRCC.
• Identification of FOXA2 as an antioxidant regulator opens potential new therapeutic strategies for HLRCC.